CSC-Mediated Immunosuppression

Cancer stem cells (CSCs) are adept at creating an immunosuppressive microenvironment, enabling them to evade immune attack. This track focuses on how CSCs manipulate immune cells, such as T-cells, macrophages, and dendritic cells, to suppress anti-tumor immune responses. Researchers explore how CSCs produce immunosuppressive factors like IL-10, TGF-β, and PD-L1, which inhibit immune cell activation and function. By targeting these immunosuppressive mechanisms, new therapeutic strategies could be developed to enhance the immune system’s ability to recognize and eliminate CSCs. This research highlights the importance of combining immunotherapy with CSC-targeted approaches to improve cancer treatment outcomes.

    Related Conference of CSC-Mediated Immunosuppression

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CSC-Mediated Immunosuppression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in